Navigation Links
TSKgel ODS-100Z and TSKgel ODS-100V column series provides a universal solution for the analysis of samples containing acidic, basic, polar & non-polar compounds


Abstract
Using high purity Type B silica, Tosoh has introduced two new columns with differing surface treatment procedures and carbon content levels to provide unique selectivities for a wide range of sample types.


Introduction
In recent years, many new octadecylsilane (ODS) chemistries have been made commercially available that offer optimized properties for select subsets of compound types. The overriding trends in the release of new stationary phases has shifted toward 1) high purity, metal free silica 2) base-deactivated surfaces 3) stronger retention of polar compounds and 4) improved reproducibilities from column to column and silica lot to silica lot. Rarely, have new ODS column types provided a universal solution to the multitude of applications being performed. Further, column selection to match the best column with the application has been difficult.

With the introduction of TSKgel ODS-100V and TSKgel ODS-100Z, excellent chromatography and selectivity can be achieved with a wide range of sample types. Due to the fact that both stationary phases use the same ultra-pure base silica with 5m particle size and 100 pores, the same chromatographic properties are achievable for columns of different lots. Different selectivities result by varying the carbon content and surface optimization. Table 1 summarizes these differences.


TSKgel ODS-100V columns are optimized for polar compounds while the TSKgel ODS-100Z are the better choice for more hydrophobic compounds. Both column types provide symmetrical peak shapes for strongly basic and acidic compounds, demonstrating the absence of accessible
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Separation of Peptides by Hydrophilic Interaction Chromatography Using TSKgel Amide-80
2. Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column
3. Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS
4. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
5. New gravity-flow column gives faster and simpler purification of histidine-tagged proteins
6. The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists
7. Effectene Transfection Reagent provides efficient gene delivery to primary neuronal cell cultures
8. Improved Quantitative Selectivity of Clenbuterol in Human Urine using High Resolution on the TSQ Quantum Mass Spectrometer
9. High resolution DNA analysis with the DNA 500 and DNA 1000 LabChip kits
10. Resolution of Linear DNA Fragments From 23 Kilobases to 6 Megabases Using Biphasic Linear Switch-Time Ramping
11. Self-Drying Vacuum Pumps... the solution for applications producing condensation

Post Your Comments:
(Date:11/23/2009)...,, SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or...nedIDCasExecutiveChairman.Dr.Carterhasasuccessfult...asthef or merChiefExecutiveOfficeratZymoGenetics,i...k,Copenhagen,Denmark. ,, (Photo: http://www.new...StevenReed,IDC,sfounderandChiefExecutiveOfficercom...
(Date:11/20/2009)..., , , , , , , , , ... , , AUDIO: , A team of scientis...iversity of Arizona, Cold Spring Harbor Laboratory... the DNA of corn. The... , , Clic... , , , , , , , ,...
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewswir...at the European Investment Fund (EIF) has entered ...he co-investment fund will be,managed by Karolinsk...portfolio of early-stage pharmaceutical and medica...6.7 M Euros in the co-investment fund. The agreeme...
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Danish...bicon cellulosic ethanol plant in Kalundborg, Denm...e of the world,s first and largest 2nd generation ...cellerase enzymes are used in the plant,s innovati... a Division of Danisco, was the first to market wi...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...ug Royalty LP 2 (DRC) announced,today the purchase...rldwide,royalty interest in PEG-INTRON for $92.5M.... 2012 should certain royalty recognition levels be...oved for the treatment of,Hepatitis C and is marke.... Speaking on behalf of DRC, Paul Kirkconnell, Ma...
...Aug. 27 NeurogesX, Inc.,(Nasdaq: NGSX ), a bioph...ain management therapies, announced today that it ...the Biotech Industry Conference on Thursday,Septem...Executive Officer,and Stephen Ghiglieri, Chief Fin...hursday, September 6, 2007 Time: 2:00 p.m. ...
...DA and Committed to Addressing Unmet Needs of ... - - Conference Call Scheduled for 4:3... Inc.,(Nasdaq: IDMI ) announced today that it rec...nd Drug Administration (FDA) after completing the,...nvestigational drug,mifamurtide (L-MTP-PE), former...
Other Biology Technology:Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 2IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 4IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 5IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 6IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 7
(Date:11/22/2009)... WASHINGTON, D.C. November 18, 2009 -- A butterfly...and used for sipping -- but it works more like a p...son University. He hopes to borrow the tricks of t...hat can sample the fluid inside of cells. , Korn...ual Meeting of the American Physical Society,s (AP...
(Date:11/22/2009)...cientists at the Brain Research Centre, a partners...of Medicine and Vancouver Coastal Health Research ...e mechanism by which brain cells die following a s...damage. The results of the study were recently pub...a stroke, many brain cells continue to die even af...
(Date:11/20/2009)... NJIT researchers are at work on many scientific a...oundation has recently provided support that total...he following investigators under the American Reco...archers have been awarded grants for investigation...d professor of physics, will enhance the capabilit...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Southern California Surgical Center 28heart411 com 29 Specializes in Mitral Valve Replacement 52836 1Southern California Surgical Center 28heart411 com 29 Specializes in Mitral Valve Replacement 52836 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 1Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 3Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 1Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 2
... The earliest humans almost certainly walked uprig...en half the speed of modern man, new research sugg...nted to the BA (British Association for the Advanc...uesday proposes that if early humans lacked an Ac...hen their ability to run would have been severely ...
...COKEEK, Md., Sept. 10 Beretta U.S.A. Corp. announ...U.S. Army and U.S. Navy for a,total of 10,576 M9 p...he,purchase orders were issued against a multi-yea...y, which serves as executive purchasing agent of t...rces. "We are always honored to be given the oppo...
...nference Embarks on New Strategic Direction in 21s... and HDD Suppliers Under One Roof, SUNNYVALE, Cal...nd its robust dynamic supply chain, IDEMA today an...he premier storage industry event, to be,held on S...a Clara,Convention Center in Santa Clara, Californ...
Other Biology News:Was ability to run early man's Achilles heel? 2Was ability to run early man's Achilles heel? 3U.S. Army and Navy Purchase Over 10,000 New Beretta M9 Pistols 2IDEMA Reveals Program Highlights for DISKCON USA 2007 2IDEMA Reveals Program Highlights for DISKCON USA 2007 3IDEMA Reveals Program Highlights for DISKCON USA 2007 4
Mouse Anti-beta-lactoglobulin Monoclonal Antibody, Unconjugated, Clone CD-2 from Cosmo Bio Co., Ltd.
...ti-AP-2 α, clone 8G8/5 GenBank Accession Nu...an AP-2alpha/gamma fusion protein corresponding to...s 278-450 of human AP-2γ Formulation: 0.1M T...e before the addition of glycerol to 30% Quality A...
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Costar 6 Well Cell Culture Plate, 9.5 cm2, 34.8 mm Diam. Well, Sterile from Sigma-Aldrich
Biology Products: